Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study
Leukemia
.
2020 Sep;34(9):2533-2535.
doi: 10.1038/s41375-020-0964-0.
Epub 2020 Jul 8.
Authors
Geneviève I C G Ector
1
,
Elisabeth G W Huijskens
2
,
Nicole M A Blijlevens
3
,
Peter E Westerweel
4
Affiliations
1
Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands. genevieve.ector@radboudumc.nl.
2
Department of Clinical Microbiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
3
Department of Haematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
4
Department of Haematology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
PMID:
32641732
PMCID:
PMC7341464
DOI:
10.1038/s41375-020-0964-0
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
Pandemics*
Pneumonia, Viral*
Prevalence
Prospective Studies
SARS-CoV-2
Severe Acute Respiratory Syndrome*